Systemic inflammation and health outcomes in patients receiving treatment for atherosclerotic cardiovascular disease
Faizan Mazhar(Karolinska Institutet), Juan Jesús Carrero(Danderyds sjukhus), Roxana Mehran(Mount Sinai Hospital), Nikolaus Marx(RWTH Aachen University), Sofia Gerward(Novo Nordisk (Denmark)), Edouard L. Fu(Leiden University Medical Center), Karolina Szummer(Karolinska University Hospital), Anne‐Laure Faucon(Karolinska Institutet), Jimmi Mathisen(Novo Nordisk (Denmark)), Simon Bertram Reuter(Novo Nordisk (Denmark))
Cited by 68
Related Papers
Health effects of dietary risks in 195 countries, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
|The Lancet|2019|5.7k
Clinical End Points in Coronary Stent Trials
|Circulation|2007|5.4k
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k
From Vulnerable Plaque to Vulnerable Patient
|Circulation|2003|2.7k
From Vulnerable Plaque to Vulnerable Patient
|Circulation|2003|2.3k